Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression

Cell Cycle

Volumn 6, Issue 16, 2007, Pages 2010-2018

  Kovalchuk, Olga ^a   Tryndyak, Volodymyr P ^b   Montgomery, Beverly ^b   Boyko, Alex ^a   Kutanzi, Kristy ^a   Zemp, Franz ^a   Warbritton, Alan R ^c   Latendresse, John R ^c   Kovalchuk, Igor ^a   Beland, Frederick A ^b   Pogribny, Igor P ^b  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b National Center for Toxicological Research   (United States)

^c Toxicologic Pathology Associates   (United States)

Author keywords

17 estradiol; Breast carcinogenesis; DNA methylation; Histone methylation; microRNA; Rat

Indexed keywords

ESTRADIOL; HISTONE; MICRORNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; MAMMARY GLAND; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN METHYLATION;

ANIMALIA; RATTUS;

EID: 34548275102     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.16.4549     Document Type: Article

References (50)

1. Schairer C, Mink PJ, Carroll L, Devesa SS. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004; 96:1311-21.
2. Raval R, Bermejo JL, Hemminki K. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening. Br J Cancer 2005; 92:162-6.
3. Simpson PT, Reis-Filho JS, Cale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005; 205:248-54.
4. Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD. Genomic instability in histologically normal breast tissues: Implications for carcinogenesis. Lancet Oncol 2004; 5:753-8.
5. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457-63.
6. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21:5462-82.
7. Feinberg AP, Tycko B. The history of cancer epigenetics. Nature Rev Cancer 2004; 4:143-5.
8. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92.
9. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89-92.
10. Flatau E, Bogenmann E, Jones PA. Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res 1983; 43:4901-5.
11. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucl Acid Res 1983; 11:6883-94.
12. Hsieh CL, Jones PA. Meddling with methylation. Nature Cell Biol 2003; 5:502-4.
13. Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77:833-8.
14. Soares J, Pinto AE, Cunha CV, André S, Barão I, Sousa JM, Cravo M. Global DNA hypomethylation in breast carcinoma:correlation with prognostic factors and tumor progression. Cancer 1999; 85:112-8.
15. Tsuda H, Takarabe T, Kanai Y, Fukutomi T, Hirohashi S. Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am J Pathology 2002; 161:859-66.
16. Robertson KD. DNA methylation and chromatin -unraveling the tangled web. Oncogene 2000; 21:5361-79.
17. Hake SB, Xiao A, Allis CD. Linking epigenetic 'language' of covalent histone modifications to cancer. Br J of Cancer 2004; 90:761-9.
18. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. Loss of acetylation at Lys 16 and trimethylation of histone H4 is a common hallmark of human cancer. Nature Genet 2005; 37:391-400.
19. Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 2005; 41:2381-402.
20. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: A small world for fine-tuning gene expression. Mamm Genome 2006; 3:189-06.
21. Carthew RW. Gene regulation by microRNAs. Curr Opin Genet Devel 2006; 16:203-8.
22. Bernstein E, Allis CD. RNA meets chromatin. Genes Devel 2006; 19:1635-55.
23. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. Specific activation of microRNA-127 with down regulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435-43.
24. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67:1424-9.
25. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8.
26. Calin GA, Croce CM. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006; 66:7390-4.
27. Iorio MI, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70.
28. Baylin S, Bestor TH. Altered methylation patterns in cancer genomes: Cause or consequence? Cancer Cell 2002; 1:299-305.
29. Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: Where do they come from? Cancer Sci 2005; 96:206-11.
30. Ye Y, Qiu TH, Kavanaugh C, Green JE. Molecular mechanisms of breast cancer progression: Lessons from mouse mammary cancer models and gene expression profiling. Breast Disease 2004; 19:69-82.
31. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. New Engl J Med 2006; 354:270-82.
32. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006; 102:89-96.
33. Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL. Ovary-intact, but not ovariectomized female ACI rats treated with 17β-estradiol rapidly develop mammary carcinoma. Carcinogenesis 1997; 18:1595-601.
34. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 2004; 101:18123-8.
35. Pogribny IP, Yi P, James SJ. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem Biophys Res Commun 1999; 262:624-8.
36. Asada K, Kotake Y, Asada R, Saunders D, Broyles RH, Towner RA, Fukui H, Floyd RA. LINE-1 hypomethylation in a choline-deficiency induced liver cancer: Dependence on feeding period. J Biomed Biotech 2006; 2006:17142.
37. Bolstad BM, Irizarry RA, Astrandand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-93.
38. Eisen MB, Spellman PT, Brown PO, Boltstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-8.
39. Rollins RA, Haghighi F, Edwards JR, Das R, Zhang MQ, Ju J, Bestor TH. Large-scale structure of genomic methylation patterns. Genome Res 2006; 16:157-63.
40. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997; 13:376-8.
41. Vertino PM, Sekowski JA, Coll JM, Applegren N, Han S, Hickey RJ, Malkas LH. DNMT1 is a component of a multiprotein DNA replication complex. Cell Cycle 2002; 1:416-23.
42. Marumoto T, Zhang D, Saya H. Aurora-A - A guardian of poles. Nat Rev Cancer 2005; 5:42-50.
43. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-43.
44. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007; 282:2130-4.
45. Volinia S, Calin G, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-61.
46. D'Cruz CM, Guntner EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 2001; 7:235-9.
47. Gonzalo S, Blasco MA. Role of Rb family in the epigenetic definition of chromatin. Cell Cycle 2005; 4:752-5.
48. Seone J. Escaping from the TGFβ anti-proliferative control. Carcinogenesis 2006; 27:2148-56.
49. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26:2799-803.
50. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103:9136-41.